These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32380782)

  • 1. Challenges in Matrix Metalloproteinases Inhibition.
    Laronha H; Carpinteiro I; Portugal J; Azul A; Polido M; Petrova KT; Salema-Oom M; Caldeira J
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32380782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
    Maskos K; Bode W
    Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of the inhibition of matrix metalloproteinases by tissue inhibitor of metalloproteinases (TIMP).
    Hutton M; Willenbrock F
    Methods Mol Biol; 2001; 151():519-32. PubMed ID: 11217325
    [No Abstract]   [Full Text] [Related]  

  • 4. MMP-TIMP interaction depends on residue 2 in TIMP-4.
    Stratmann B; Farr M; Tschesche H
    FEBS Lett; 2001 Nov; 507(3):285-7. PubMed ID: 11696356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in invasion of tumours of neuroepithelial tissue].
    Bogaczewicz J; Jasielski P; Mosiewicz A; Trojanowski T; Suchozebrska-Jesionek D; Stryjecka-Zimmer M
    Neurol Neurochir Pol; 2006; 40(5):404-12. PubMed ID: 17103354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and periodontal diseases.
    Sapna G; Gokul S; Bagri-Manjrekar K
    Oral Dis; 2014 Sep; 20(6):538-50. PubMed ID: 23849049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based molecular insights into matrix metalloproteinase inhibitors in cancer treatments.
    Lin H; Xu P; Huang M
    Future Med Chem; 2022 Jan; 14(1):35-51. PubMed ID: 34779649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue inhibitor of metalloproteinases-4. The road less traveled.
    Melendez-Zajgla J; Del Pozo L; Ceballos G; Maldonado V
    Mol Cancer; 2008 Nov; 7():85. PubMed ID: 19025595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis.
    George SJ
    Expert Opin Investig Drugs; 2000 May; 9(5):993-1007. PubMed ID: 11060722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous and synthetic MMP inhibitors in CNS physiopathology.
    Baranger K; Rivera S; Liechti FD; Grandgirard D; Bigas J; Seco J; Tarrago T; Leib SL; Khrestchatisky M
    Prog Brain Res; 2014; 214():313-51. PubMed ID: 25410364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis.
    Khasigov PZ; Podobed OV; Gracheva TS; Salbiev KD; Grachev SV; Berezov TT
    Biochemistry (Mosc); 2003 Jul; 68(7):711-7. PubMed ID: 12946252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metalloproteinases. Structure and function].
    Lipka D; Boratyński J
    Postepy Hig Med Dosw (Online); 2008 Jul; 62():328-36. PubMed ID: 18614970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases.
    Birkedal-Hansen H; Yamada S; Windsor J; Pollard AH; Lyons G; Stetler-Stevenson W; Birkedal-Hansen B
    Curr Protoc Cell Biol; 2008 Sep; Chapter 10():Unit 10.8. PubMed ID: 18819088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives and New Aspects of Metalloproteinases' Inhibitors in the Therapy of CNS Disorders: From Chemistry to Medicine.
    Boguszewska-Czubara A; Budzynska B; Skalicka-Wozniak K; Kurzepa J
    Curr Med Chem; 2019; 26(18):3208-3224. PubMed ID: 29756562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials.
    Jones JA; McNally AK; Chang DT; Qin LA; Meyerson H; Colton E; Kwon IL; Matsuda T; Anderson JM
    J Biomed Mater Res A; 2008 Jan; 84(1):158-66. PubMed ID: 17607751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human fetal testis and ovary.
    Robinson LL; Sznajder NA; Riley SC; Anderson RA
    Mol Hum Reprod; 2001 Jul; 7(7):641-8. PubMed ID: 11420387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
    Briasoulis A; Tousoulis D; Papageorgiou N; Kampoli AM; Androulakis E; Antoniades C; Tsiamis E; Latsios G; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1214-21. PubMed ID: 22519451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R; Nagase H
    Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
    Smith MF; Ricke WA; Bakke LJ; Dow MP; Smith GW
    Mol Cell Endocrinol; 2002 May; 191(1):45-56. PubMed ID: 12044918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.